David Hallal - Mar 10, 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role: Director, 10%+ Owner
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Stock symbol: ALVR
Transactions as of: Mar 10, 2022
Transactions value $: -$491,850
Form type: 4
Date filed: 3/11/2022, 06:14 PM
Previous filing: Jan 25, 2022
Next filing: Apr 22, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Sale	-$306K	-40.5K	-1.83%	$7.55	2.17M	Mar 10, 2022	Direct	F1, F2
transaction	ALVR	Common Stock	Sale	-$186K	-25.2K	-1.16%	$7.37	2.15M	Mar 11, 2022	Direct	F1, F3
holding	ALVR	Common Stock						13.4M	Mar 10, 2022	See Footnote	F4
holding	ALVR	Common Stock						1.12M	Mar 10, 2022	See Footnote	F5
holding	ALVR	Common Stock						738K	Mar 10, 2022	See Footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 7, 2022 to cover tax withholding obligations upon the vesting and settlement of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.27 to $7.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.18 to $7.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
F4	Shares held by ElevateBio LLC ("ElevateBio"). The Reporting Person is the Chairman and Chief Executive Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F5	Shares held by The Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F6	Shares held by Terrie A. Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.